Hanif Ardiansyah Sulistya

Hanif Ardiansyah Sulistya

Auto-generated profile, based on publicly available information

Hanif Ardiansyah Sulistya

Faculty of Medicine, Airlangga University, Surabaya, Indonesia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WHWigaviola Socha Purnamaasri Harmadha
Wigaviola Socha Purnamaasri Harmadha
FMFarizal Rizky Muharram
Farizal Rizky Muharram
RGRenato Simoes Gaspar
Renato Simoes Gaspar
ZAZahras Azimuth
Zahras Azimuth
HSHanif Ardiansyah Sulistya
Hanif Ardiansyah Sulistya
RPRendra Mahardhika Putra
Rendra Mahardhika Putra
In the last two decades, there has been a discernible shift in the distribution of mortality attributed to cardiovascular disease (CVD) between developing and developed nations; in developed nations, the percentage of deaths caused by CVD decreased from 48% in 1990 to 43% in 2010, while in developing nations, they increased from 18% to 25%. In Indonesia, CVD death has increased substantially and remained elevated in the last ten years. Current behavioral and metabolic risk factors, including hyperglycemia, obesity, dyslipidemia, hypertension, and smoking, enhance the risk of CVD mortality, according to several studies. We undertook a study to determine whether the increase in mortality and incidence of CVD can be attributed to changes in the most common metabolic and behavioral risk factors from 2000 to 2019 across 34 Indonesian provinces. Data from 34 province for CVD incidence and mortality and data on changes in metabolic and behavioural risk factors between 2000 and 2019 in Indonesia were obtained from the Global Burden study (GBD) by The Institute of Health Metrics and Evaluation (IHME). A statistical model was applied to calculate the fatalities attributable to the risk factors change using Population attributable fractions (PAF) and baseline year death numbers. Furthermore, we ran multivariate regressions on Summary Exposure Value of risk factors associated with the increasing mortality, incidence rates in a lag year analysis. R software used to measure heteroscedasticity-consistent standard errors with coeftest and coefci. Covariates were added to adjusted models, including the Socio-demographic Index, Primary health care facilities coverage, and GDP per capita. The age-standardized mortality rate for CVD from 2000 to 2019 in Indonesia, increased from 356.05 to 412.46 deaths per 100,000 population among men and decreased from 357.52 to 354.07 deaths per 100,000 population among women, resulting in an increase of 270.928 per 100,0000 inhabitants of CVD deaths. In the same period, there was an increase in exposure to risk factors such as obesity by +9%, smoking by +1%, dyslipidemia by +1.3%, hyperglycemia by +2%, and hypertension by +1.2%. During this time span, an additional 14,517 men and 17,917 women died from CVD, which was attributable to higher obesity exposure. We apply multivariate regression with province-fixed and year-fixed analysis and find strong correlation between hyperglycemia in women (6; 95%CI 0 to 12, death per 1-point increase in hyperglycemia exposure) with an increasing death rate in ischemic heart disease. We also performed a year lag analysis and discovered a robust association between high low density lipoprotein (LDL) levels in men and women and the growing incidence of ischemic heart disease. The association between a 10-year lag of high LDL and the incidence of ischemic heart disease was five times stronger than that observed for other risk factors, particularly in men (5; 95%CI 2 to 8, incidence per 1-point increase in high LDL exposure). Hyperglycemia in women is an important risk factor associated with increasing mortality due to Ischemic Heart Disease (IHD) in Indonesia This study also revealed that the presence of high LDL in both men and women were associated with an increase incidence of IHD that manifested several years subsequent to exposure to the risk factor. Additionally, the highest cardiovascular death portion were attributed to obesity. These findings suggest that policymakers should control high LDL and hyperglycemia 10 years earlier prior to the occurrence of IHD and employ personalized therapy to regulate associated risks.

17 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BTBrahmana Askandar Tjokroprawiro
Brahmana Askandar Tjokroprawiro
KNKhoirunnisa Novitasari
Khoirunnisa Novitasari
RURenata Alya Ulhaq
Renata Alya Ulhaq
HSHanif Ardiansyah Sulistya
Hanif Ardiansyah Sulistya
SMSANTI MARTINI
SANTI MARTINI
Introduction: Ovarian cancer is one of the most lethal gynecological cancers. Despite diagnosis and treatment advances, survival rates have not increased over the past 32 years. This study estimated and reported the global burden of ovarian cancer during the past 32 years to inform preventative and control strategies. Methods: We examined ovarian cancer incidence, mortality, and disability-adjusted life years (DALYs) using age-standardized rates from the Global Burden of Disease, Injuries, and Risk Factors Study 2021. high body mass index and occupational asbestos exposure were linked with death and DALYs. Data are presented as averages with 95% uncertainty intervals (UIs). Results: Indonesia had 13 250 (8 574–21 565) ovarian cancer cases in 2021, with 5 296 (3 520–8958) deaths and 186 917 (121 866–309 820) DALYs. The burden increased by 233.53% for new cases, 221.95% for mortalities, and 206.65% for DALYs. The age-standardized rate also increased from 1990 to 2021. Ovarian cancer burden increased with age but declined in the 50+ year age group. According to the sociodemographic index, the gross domestic product per capita and number of obstetricians and oncologic gynecologists in provinces showed different trends. Conclusions: Indonesian ovarian cancer rates are rising despite gynecologic oncologists in 24 of 34 provinces. These findings will help policymakers and healthcare providers identify ovarian cancer prevention and control gaps.

5 January 2024 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
BTBrahmana Askandar Tjokroprawiro
Brahmana Askandar Tjokroprawiro
HSHanif Ardiansyah Sulistya
Hanif Ardiansyah Sulistya
FMFarizal Rizky Muharram
Farizal Rizky Muharram
RURenata Alya Ulhaq
Renata Alya Ulhaq
AIAlifina Izza
Alifina Izza
MAMuhammad Muhibuddin Hilmy Asari
Muhammad Muhibuddin Hilmy Asari
Background: Ensuring timely access to safe and affordable surgery within a travel time of a 2-h drive or 30-min walk is crucial for achieving universal health coverage, as endorsed by the Lancet Commission on Global Surgery (LCoGS). In this study, we aimed to quantify the percentage of Indonesian women of reproductive age (WRA) who can access a hospital with emergency obstetric and gynecological services within this time frame. In addition, we aimed to identify the underserved populations. Methods: We identified hospitals across 38 provinces using the database from the Indonesian Society of Obstetricians and Gynecologists (ISOG) and the Indonesian Ministry of Health database that provide emergency obstetric services. We conducted geospatial analysis using the cost of distance and service area tools in ArcGIS Pro with WRA population data derived from Facebook’s high-resolution settlement layer (HRSL) maps. Results: Of the 3,202 recorded hospitals, 2,855 (89.2%) had an obstetric gynecologist (OBGYN). The workforce of 5,305 OBGYNs consisted of 4,857 (91.6%) actively practicing OBGYNs, of which 3,405 (64.2%) practice in hospitals only. Of the WRA population, 94.5% lived within 2 h of a facility. However, eight provinces had low timely access to these hospitals. Conclusion: Indonesia provides universal health coverage; however, stark disparities exist in the geographic access to emergency obstetric surgical care in certain provinces. Geospatial mapping and survey data work together to aid in assessing the strength of the surgical system and in identifying gaps in geographic access to timely surgery.

23 March 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
BTBrahmana Askandar Tjokroprawiro
Brahmana Askandar Tjokroprawiro
HSHanif Ardiansyah Sulistya
Hanif Ardiansyah Sulistya
ARAnnisa Aghnia Rahma
Annisa Aghnia Rahma
KNKhoirunnisa Novitasari
Khoirunnisa Novitasari
RURenata Alya Ulhaq
Renata Alya Ulhaq
TATricia Dewi Anggraeni
Tricia Dewi Anggraeni
Objective This study aimed to identify underserved regions and evaluate the population coverage based on travel time and distance to hospitals with gynaecologic oncologists in Indonesia. Methods The travel time and distance to hospitals with gynaecologic oncologists were evaluated using the Quantum Geographic Information System. Data from 139 gynaecologic oncologists and their affiliated hospitals were obtained from the Indonesian Society of Gynecologic Oncologists (November 2024) and cross-referenced with the Ministry of Health records. The female population density data were sourced from Facebook’s high-resolution settlement layer. Isochrones were generated to estimate travel times and distances using zonal statistics, which facilitated the calculation of population coverage. Results A total of 139 gynaecologic oncologists were identified nationwide, practising in 243 hospitals (7.6% of the 3202 hospitals in Indonesia), with a concentration in Java (60.4%). 11 of the 38 provinces lack sub-specialists. Population coverage varies sharply: the travel time to a hospital with gynaecologic oncologists is ≤2 hours for 79.1% of women in Java, compared with 4.9% in Papua; overall, 34.4% reside more than 100 km away from hospitals with gynaecologic oncologists. Hospitals with gynaecologic oncologists are predominantly urban class B general hospitals, and 83.1% participate in the National Health Insurance Schemes. Exploratory district-level correlations showed positive associations between the number of such hospitals and total female population (r=0.44, p<0.001), female life expectancy (r=0.29, p<0.001), per-capita expenditure (r=0.54, p<0.001), female population density (r=0.68, p<0.001), female Human Development Index (r=0.4, p<0.001) and a negative association with land area size (r=–0.15, p<0.001). Conclusions Gynaecological oncology services in Indonesia remain heavily concentrated in Java, leaving nearly one-fifth of women residing more than 100 km away. The travel time is greater than 2 hours for many. Targeted expansion of the gynaecologic oncologists workforce, diagnostic and treatment infrastructure, and sustainable financing mechanisms are required to close these gaps.

1 January 2024 in Biomolecular and Health Science Journal
Verified
Journal Article
Open access
MMMohammad Agung Marzah
Mohammad Agung Marzah
RSrosantia sarassari
rosantia sarassari
DSDodi Safari
Dodi Safari
YMYustinus Maladan
Yustinus Maladan
WSWahyu Setyarini
Wahyu Setyarini
EKEko Budi Koendhori
Eko Budi Koendhori
Introduction: Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase (AmpC-BL) in Enterobacteriaceae are a global threat. Coproduction of AmpC-BL and ESBL reduces therapeutic options, with more resistance against cephamycin and beta-lactamase inhibitor combinations. This study determines the proportion, incidence, and distribution of AmpC-BL-resistant genes in clinically isolated ESBL-producing Escherichia coli, completing its scarce data in Indonesia. Methods: The samples in this study were ESBL-producing E. coli from blood and urine specimens, confirmed by BD Phoenix semiautomatic examination combined with cefoxitin disk screening method. Confirmation tests of AmpC-BL used the AmpC-disk method and the polymerase chain reaction method. Results: Thirteen (27.8%) of 108 E. coli isolates were nonsusceptible to cefoxitin, and 3 (11.5%) isolates were confirmed to produce AmpC-BL and contained AmpC-BL CITM gene. Of the 3 AmpC-BL and ESBL coproduction isolates, one isolate was a copresentation of ESBL and AmpC-BL genes, namely blaTEM and CITM. Fisher’s exact test showed that the coproduction of AmpC-BL in ESBL-producing isolates was associated with reduced susceptibility to cefoxitin (P = 0.020) and amoxicillin-clavulanate (P = 0.048) compared to isolates producing ESBL alone. The effect of ESBL and AmpC-BL coproduction on reducing susceptibility to carbapenems needs further investigation. Conclusions: AmpC coproduction was found in 3 (2.8%) of 108 ESBL-producing E. coli isolates, and one isolate copresented AmpC-BL and ESBL coding genes blaTEM and CITM. These three isolates were associated with widened antibiotic resistance to cefoxitin and amoxicillin--clavulanate compared to isolates producing ESBL alone.

1 January 2026 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
BTBrahmana Askandar Tjokroprawiro
Brahmana Askandar Tjokroprawiro
KNKhoirunnisa Novitasari
Khoirunnisa Novitasari
RURenata Alya Ulhaq
Renata Alya Ulhaq
HSHanif Ardiansyah Sulistya
Hanif Ardiansyah Sulistya
TITeuku Mirza Iskandar
Teuku Mirza Iskandar
Background: Leiomyoma‐associated cutaneous sinus tracts are exceptionally rare and typically associated with prior uterine surgeries, such as cesarean section or myomectomy. Fistula formation from an infected uterine leiomyoma involving the uterine parenchyma, without prior myomectomy, represents an uncommon clinical presentation. Case: A 22‐year‐old woman with a history of cesarean section 5 months prior presented with purulent discharge from an abdominal mass. Imaging revealed a large uterine mass containing gas, with a fistulous tract extending to the abdominal skin. Laparotomy confirmed a fistulous tract extending from the abdominal skin to an infected leiomyoma within the uterine fundal parenchyma, without demonstrable communication with the endometrial cavity. Surgical intervention consisted of fistula closure, myomectomy, and drainage. Histopathological examination confirmed the presence of a uterine leiomyoma with chronic suppurative inflammation, consistent with an infected myoma. The patient remained asymptomatic for 15 months following surgery. Conclusion: This case highlights a rare variant of leiomyoma‐associated cutaneous sinus tract arising from an infected uterine leiomyoma involving the uterine parenchyma. Careful diagnostic evaluation and tailored surgical management resulted in complete recovery and a favorable long‐term outcome.